Abbott: A bio-device to control blood glucose and ketone levels

2022: Announcement of a device for continuous monitoring of glucose and ketones in blood

On June 3, 2022, Abbott announced a bio-device that is capable of continuously monitoring glucose and ketone body levels in a single sensor. The device is designed to improve the lives of people with life-threatening or irreversibly weakening diseases for the human body.

The glucose-ketone sensor will be the same size as Abbott's FreeStyle Libre 3 sensor, the world's smallest and thinnest 1.2 continuous glucose monitoring (CGM) sensor, and will connect to Abbott's digital ecosystem, including personal mobile applications and cloud data management software for remote monitoring by healthcare professionals.

Abbott unveils wearable device to continuously monitor blood glucose and ketone levels

The continuous glucose-ketone monitor is particularly important for people with diabetes who may be at increased risk of developing diabetic ketoacidosis (DKA), a potentially life-threatening condition where blood ketone levels rise to dangerous levels.

{{quote 'Abbott revolutionized diabetes care by developing FreeStyle Libre technology, which is the number one continuous glucose monitor used by 4 million people worldwide! We are developing our glucose-ketone monitoring system with excellent detection technology that will work in tandem with industry-leading insulin pumps, creating a best-in-class solution. We are confident that this will be the next big advance in diabetes technology and a breakthrough for people with diabetes, especially those at risk of developing diabetic ketoacidosis, "said Jared Watkin, Senior Vice President of Abbott Diabetes Care. }} DKA is a growing problem worldwide with hundreds of thousands of emergency department visits and DKA hospitalizations each year in the U.S. However, as of June 2022, few people with diabetes regularly monitor ketone levels, as existing testing methods, usually through blood or urine, are costly and burdensome for users. The addition of continuous ketone monitoring to the continuous glucose monitoring system eliminates the need for separate ketone testing.^[1]

Notes